Why Hyperthyroidism Increases Arrhythmia Risk
Hyperthyroidism increases arrhythmia risk through multiple direct electrophysiological mechanisms: shortened action potential duration and refractory periods, increased automaticity and triggered activity, slowed conduction velocity creating reentry circuits, plus indirect effects from increased heart rate, left ventricular hypertrophy with elevated atrial pressures, and heightened myocardial calcium handling.
Primary Electrophysiological Mechanisms
The fundamental problem is that excess thyroid hormones directly alter cardiac electrical properties at the cellular level through both genomic and non-genomic pathways 1:
Atrial Arrhythmias (Most Common)
- Shortened refractory periods combined with slowed conduction velocity create the perfect substrate for multiple intraatrial reentry circuits 1
- Increased automaticity and triggered activity initiate ectopic beats that can trigger atrial fibrillation 2
- The shortened action potential duration makes reentry more likely since effective refractory periods are abbreviated 2
- Atrial fibrillation occurs in up to 15% of hyperthyroid patients versus 4% in the general population 2
Ventricular Arrhythmias (Less Common but Serious)
- Increased triggered activity under conditions of myoplasmic calcium overload makes ventricular tissue more prone to arrhythmias 3
- QT interval prolongation and increased QT dispersion create substrate for ventricular tachyarrhythmias 1
- Epidemiological data link elevated T4 levels with ventricular arrhythmias and sudden cardiac death, particularly in patients with underlying cardiac disease 1
Secondary Hemodynamic Mechanisms
Beyond direct electrical effects, hyperthyroidism creates structural and hemodynamic changes:
- Left ventricular hypertrophy with impaired ventricular relaxation elevates left atrial pressure 2
- Increased resting heart rate can cause myocardial ischemia, further promoting arrhythmias 2
- High-output state stresses the cardiovascular system 4
Clinical Implications from Guidelines
The American Thyroid Association/American Association of Clinical Endocrinologists guidelines emphasize that elderly patients and those with cardiovascular disease or severe hyperthyroidism are at highest risk for arrhythmic complications 5. This is why:
- Beta-blockade is recommended before radioactive iodine therapy in vulnerable patients to prevent post-treatment tachyarrhythmias including atrial fibrillation and atrial flutter 5
- Worsened chemical hyperthyroidism after treatment can trigger supraventricular tachycardia in susceptible patients 5
Important Caveats
The arrhythmia risk is not simply from increased heart rate or adrenergic stimulation alone. Research demonstrates that enhanced reperfusion arrhythmias in hyperthyroid hearts were not reduced by nadolol (beta-blocker) or prazosin (alpha-blocker) in isolation, suggesting the primary mechanism is intrinsic electrical remodeling rather than just autonomic effects 3.
Subclinical hyperthyroidism also carries risk, with a 3-fold increase in atrial fibrillation development even without overt symptoms 2. This means TSH screening is important in patients presenting with new-onset arrhythmias.
The relationship is dose-dependent: atrial fibrillation occurs in both euthyroidism and hyperthyroidism but shows clear association with T4 levels 1, and is more common with T3 toxicosis 2.